Oscar Health OSCR Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Oscar Health in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oscar Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oscar Health's cash & equivalents?
- Oscar Health (OSCR) reported cash & equivalents of $4.83B in Q1 2026.
- How has Oscar Health's cash & equivalents changed year-over-year?
- Oscar Health's cash & equivalents increased by 113.7% year-over-year, from $2.26B to $4.83B.
- What is the long-term trend for Oscar Health's cash & equivalents?
- Over 5 years (2020 to 2025), Oscar Health's cash & equivalents has grown at a 27.7% compound annual growth rate (CAGR), from $826.33M to $2.8B.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid assets the company has on hand.
- How do you interpret cash & equivalents?
- An increase suggests strong liquidity and financial flexibility, while a decrease may indicate heavy cash burn or capital deployment.
- How does cash & equivalents compare across companies?
- Standard across all industries; peers typically maintain levels sufficient to cover several months of operating expenses.